rs769259446
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_003901.4(SGPL1):c.665G>A(p.Arg222Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,494 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003901.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 14 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251154Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135760
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461494Hom.: 0 Cov.: 30 AF XY: 0.00000688 AC XY: 5AN XY: 727066
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Nephrotic syndrome 14 Pathogenic:3Other:1
- -
- -
- -
- -
not provided Pathogenic:1
ClinVar contains an entry for this variant (Variation ID: 430861). This variant has been observed in individual(s) with clinical features of SGPL1-related conditions (PMID: 28165343, 30517686, 31130284). It has also been observed to segregate with disease in related individuals. This variant is present in population databases (rs769259446, ExAC 0.006%). This sequence change replaces arginine with glutamine at codon 222 of the SGPL1 protein (p.Arg222Gln). The arginine residue is highly conserved and there is a small physicochemical difference between arginine and glutamine. Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Arg222 amino acid residue in SGPL1. Other variant(s) that disrupt this residue have been observed in individuals with SGPL1-related conditions (PMID: 28165339), which suggests that this may be a clinically significant amino acid residue. Experimental studies have shown that this variant affects SGPL1 protein function (PMID: 28165343). -
Nephrotic syndrome Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at